https://doi.org/10.4081/reumatismo.2016.889
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient
Submitted: 5 May 2016
Accepted: 1 August 2016
Published: 9 September 2016
Accepted: 1 August 2016
Abstract Views: 1627
PDF: 1133
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
How to Cite
Bruni, C., Bellando-Randone, S., Gargani, L., Picano, E., Pingitore, A., Matucci-Cerinic, M., & Guiducci, S. (2016). Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. Reumatismo, 68(2), 109–111. https://doi.org/10.4081/reumatismo.2016.889
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Similar Articles
- D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes, Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series , Reumatismo: Early Access
- A. Alunno, G. Nocentini, O. Bistoni, M.G. Petrillo, E. Bartoloni Bocci, S. Ronchetti, E. Lo Vaglio, C. Riccardi, R. Gerli, Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity , Reumatismo: Vol. 64 No. 5 (2012)
- A. Aghabiklooei, N. Zamani, H. Hassanian-Moghaddam, S. Nasouhi, M. Mashayekhian, Acute colchicine overdose: report of three cases , Reumatismo: Vol. 65 No. 6 (2013)
- M. Rampudda, P. Marson, G. Pasero, The main stages in the history of systemic lupus erythematosus , Reumatismo: Vol. 61 No. 2 (2009)
- M. Ferrito, G. Cincinelli, M. Manara, R. Di Taranto, E.G. Favalli, R. Caporali, Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients , Reumatismo: Vol. 75 No. 2 (2023)
- R. Scolozzi, A. Boccafogli, L. Vicentini, Hyper-IgD syndrome and hereditary periodic fever syndromes , Reumatismo: Vol. 56 No. 3 (2004)
- M. Todoerti, W. Maglione, E. Bernero, A. Bortoluzzi, M. Colaci, E. Galuppi, S. Paolino, R. Talarico, M. Cutolo, C. Ferri, F. Trotta, S. Bombardieri, C.M. Montecucco, L. Sinigaglia, Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis , Reumatismo: Vol. 65 No. 5 (2013)
- I. Acosta-Colman, Z. Morel, A. Ayala Lugo, V. Jolly, I. de Guillén, P. Langjahr, M. Vazquez, M.T Martínez de Filártiga, M.E. Acosta, Clinical features and genetic biomarkers associated with different phenotypes of systemic lupus erythematosus in Paraguayan patients , Reumatismo: Vol. 75 No. 2 (2023)
- L. Fioravante da Silveira, A. Zago, D. Zanchet, D. Chemello, Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report , Reumatismo: Vol. 75 No. 2 (2023)
- C. Garufi, S. Mancuso, F. Ceccarelli, L. Caruso, C. Alessandri, M. Di Franco, R. Priori, V. Riccieri, R. Scrivo, S. Truglia, F. Conti, F.R. Spinelli, PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors , Reumatismo: Early Access
<< < 15 16 17 18 19 20 21 22 23 24 > >>
You may also start an advanced similarity search for this article.
